Prognostic Impact of BRAF and KRAS Mutation in Patients with Colorectal and Appendiceal Peritoneal Metastases Scheduled for CRS and HIPEC. [electronic resource]
Producer: 20200609Description: 293-300 p. digitalISSN:- 1534-4681
- Adenocarcinoma -- genetics
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Appendiceal Neoplasms -- genetics
- Biomarkers, Tumor -- genetics
- Colorectal Neoplasms -- genetics
- Combined Modality Therapy
- Cytoreduction Surgical Procedures
- Female
- Humans
- Hyperthermia, Induced
- Male
- Middle Aged
- Mutation
- Peritoneal Neoplasms -- secondary
- Prognosis
- Proto-Oncogene Proteins B-raf -- genetics
- Proto-Oncogene Proteins p21(ras) -- genetics
- Survival Rate
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.